Skip to content

Clinical trials

Terminated Observational Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Observational Status: Terminated Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20072
20083
20091
20101
20121
20131
20151
20181
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vanderbilt-Ingram Cancer Center3
AIDS Malignancy Consortium1
Celgene1
City of Hope Medical Center1
Columbia University1
Hoffmann-La Roche1
Juno Therapeutics, a Subsidiary of Celgene1
Mustang Bio1
National Institutes of Health Clinical Center (CC)1
OHSU Knight Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse16
Leukemia, Lymphocytic, Chronic, B-Cell11
Lymphoma, Follicular11
Lymphoma, Non-Hodgkin11
Lymphoma, Mantle-Cell10
Burkitt Lymphoma9
Congenital Abnormalities9
Hodgkin Disease9
Leukemia, Hairy Cell9
Leukemia, Myeloid, Acute9

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.